133 related articles for article (PubMed ID: 27311476)
1. QSAR Models at the US FDA/NCTR.
Hong H; Chen M; Ng HW; Tong W
Methods Mol Biol; 2016; 1425():431-59. PubMed ID: 27311476
[TBL] [Abstract][Full Text] [Related]
2. Computational toxicology approaches at the US Food and Drug Administration.
Yang C; Valerio LG; Arvidson KB
Altern Lab Anim; 2009 Nov; 37(5):523-31. PubMed ID: 20017581
[TBL] [Abstract][Full Text] [Related]
3. The importance of molecular structures, endpoints' values, and predictivity parameters in QSAR research: QSAR analysis of a series of estrogen receptor binders.
Li J; Gramatica P
Mol Divers; 2010 Nov; 14(4):687-96. PubMed ID: 19921452
[TBL] [Abstract][Full Text] [Related]
4. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
5. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
6. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
7. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products.
Kruhlak NL; Contrera JF; Benz RD; Matthews EJ
Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485
[TBL] [Abstract][Full Text] [Related]
8. Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics.
Hong H; Xie Q; Ge W; Qian F; Fang H; Shi L; Su Z; Perkins R; Tong W
J Chem Inf Model; 2008 Jul; 48(7):1337-44. PubMed ID: 18564836
[TBL] [Abstract][Full Text] [Related]
9. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
Hong H; Thakkar S; Chen M; Tong W
Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
[TBL] [Abstract][Full Text] [Related]
10. Quick and efficient quantitative predictions of androgen receptor binding affinity for screening Endocrine Disruptor Chemicals using 2D-QSAR and Chemical Read-Across.
Banerjee A; De P; Kumar V; Kar S; Roy K
Chemosphere; 2022 Dec; 309(Pt 1):136579. PubMed ID: 36174732
[TBL] [Abstract][Full Text] [Related]
11. EADB: an estrogenic activity database for assessing potential endocrine activity.
Shen J; Xu L; Fang H; Richard AM; Bray JD; Judson RS; Zhou G; Colatsky TJ; Aungst JL; Teng C; Harris SC; Ge W; Dai SY; Su Z; Jacobs AC; Harrouk W; Perkins R; Tong W; Hong H
Toxicol Sci; 2013 Oct; 135(2):277-91. PubMed ID: 23897986
[TBL] [Abstract][Full Text] [Related]
12. An in silico ensemble method for lead discovery: decision forest.
Hong H; Tong W; Xie Q; Fang H; Perkins R
SAR QSAR Environ Res; 2005 Aug; 16(4):339-47. PubMed ID: 16234175
[TBL] [Abstract][Full Text] [Related]
13. Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety.
Arvidson KB; Chanderbhan R; Muldoon-Jacobs K; Mayer J; Ogungbesan A
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):793-6. PubMed ID: 20491519
[TBL] [Abstract][Full Text] [Related]
14. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
Valerio LG; Cross KP
Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
[TBL] [Abstract][Full Text] [Related]
15. Using kernel alignment to select features of molecular descriptors in a QSAR study.
Wong WW; Burkowski FJ
IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
[TBL] [Abstract][Full Text] [Related]
16. Prediction of acute toxicity in fish by using QSAR methods and chemical modes of action.
Lozano S; Lescot E; Halm MP; Lepailleur A; Bureau R; Rault S
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):195-203. PubMed ID: 19874208
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
[TBL] [Abstract][Full Text] [Related]
18. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
Waller CL
J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
[TBL] [Abstract][Full Text] [Related]
19. QSAR Methods.
Gini G
Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
[TBL] [Abstract][Full Text] [Related]
20. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
